Prat Aleix

Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study

N. Viñolas, P. Galván, N. Basté, 2023, Cancer Immunology, Immunotherapy.

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

C. Perou, E. Winer, J. Parker, 2014, Breast Cancer Research and Treatment.